80005-131-38 : NDC 2026 Code

80005-131-38 : Clindamycin Phosphate Topical ( Clindamycin Phosphate )

Additionally :

You can get information about “80005-131-38” NDC code in 80005-131-38 in HTML format

HTML | 80005-131-38 in TXT (Plain Text) format

TXT | 80005-131-38 in PDF (Portable Document Format)

PDF | 80005-131-38 in XML format

XML formats.

NDC Code : 80005-131-38 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "80005-131-38",
    "PackageDescription": "69 APPLICATOR in 1 JAR (80005-131-38)  / 1 mL in 1 APPLICATOR",
    "NDC11Code": "80005-0131-38",
    "ProductNDC": "80005-131",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Clindamycin Phosphate",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Clindamycin Phosphate Topical",
    "DosageFormName": "SOLUTION",
    "RouteName": "TOPICAL",
    "StartMarketingDate": "20250616",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA219612",
    "LabelerName": "Carnegie Pharmaceuticals, LLC",
    "SubstanceName": "CLINDAMYCIN PHOSPHATE",
    "StrengthNumber": "10",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-05",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20251215",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}